Clinical trial
Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain…
NCT00401973 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00401973 |
|---|---|
| Title | Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine |
| Official title | The Assessment of the Safety, Efficacy, and Practicality of an Algorithm Including Amantadine, Metformin and Zonisamide for the Prevention of Olanzapine-Associated Weight Gain in Outpatients With Schizophrenia |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorders |
| Intervention type | Behavioral, Drug |
| Interventions | olanzapine, amantadine, metformin, zonisamide, Wellness education |
| Enrollment | 199 |
| Start date | Nov 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Nov 22, 2006 |
| Last update posted | Oct 6, 2009 |
| Countries | Brazil, Israel, Mexico, Puerto Rico, Russia, South Korea, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: